APT 2026 Committees
| Presiding Chair | Kathryn Fraser, Merck |
| Presiding Chair-Elect | Michael Kerins, Eli Lilly |
Discovery
| Chair | Kathryn Fraser, Merck |
| Chair-Elect | Michael Kerins, Eli Lilly |
|
Jodi Goodwin, Takeda Jonathan Heyen, Treeline Bio Satoko Kiyota, Genentech Prathap Kumar Mahalingaiah, AstraZeneca Rama Pai, Merck Sunjay Sethi, IDEAYA Biosciences Yoav Timsit, Novartis Gina Yanochko, Johnson & Johnson Helen Yu, Vertex |
Development
| Chair | Yuan Lu, CinRx Pharma |
| Chair-Elect | |
|
Surekha Akella, AbbVie Satheesh Anand, Boehringer Ingelheim Joe Cichocki, Vertex Birgit Fogal, Sanofi Emma Karey, AstraZeneca Yu-Mee Kim, Genentech Heather Kowalski Jon Maher, Pliant Christine Mollica, Amgen Betty Pettersen, Alexion Daniella Pizzurro, Merck Michael Santostefano, Merck Radha Sura, Gilead Nardos Tassew, The Janssen Pharmaceutical Companies of Johnson & Johnson |